One-liner#

Evaluate hypoglycemia symptoms using Whipple’s triad; distinguish medication-induced (diabetics) from spontaneous hypoglycemia (non-diabetics); adjust diabetes regimens and investigate rare causes when appropriate.

Quick nav#

• Red flags / send to ED
• Key history
• Focused exam
• Differential (quick pattern recognition)
• Workup
• Initial management
• Management by diagnosis
• Follow-up
• Patient instructions
• Smartphrase snippets

Red flags / send to ED#

• Altered mental status or seizure from hypoglycemia → call 911
• Unable to take oral glucose (unconscious, seizing, severe confusion) → call 911; needs IV dextrose or glucagon
• Recurrent severe hypoglycemia in diabetic patient → same-day evaluation; adjust regimen
• Hypoglycemia in non-diabetic with concerning features (weight loss, abdominal mass) → urgent workup
• Suspected sulfonylurea overdose (intentional or accidental) → ED for observation (prolonged hypoglycemia risk)

Severe hypoglycemia definition: Requires assistance from another person to treat

Key history#

Whipple’s triad (required for diagnosis of hypoglycemic disorder):

1. Symptoms consistent with hypoglycemia
2. Low plasma glucose at time of symptoms (<70 mg/dL, or <55 mg/dL for non-diabetics)
3. Resolution of symptoms when glucose is raised

Autonomic (adrenergic) symptoms:

• Shakiness, tremor
• Sweating, diaphoresis
• Palpitations, racing heart
• Anxiety, nervousness
• Hunger
• Pallor
• Tingling (perioral, fingertips)

Neuroglycopenic symptoms (brain glucose deprivation):

• Confusion, difficulty concentrating
• Slurred speech
• Blurred vision
• Weakness, fatigue
• Drowsiness
• Behavioral changes, irritability
• Seizures
• Loss of consciousness

Hypoglycemia unawareness:

• Loss of warning symptoms (autonomic symptoms blunted)
• Common in longstanding diabetes, frequent hypoglycemia, elderly
• Patient may progress directly to neuroglycopenic symptoms
• Very dangerous—increases risk of severe hypoglycemia

Timing of symptoms:

• Fasting (overnight, before meals): think insulinoma, medication effect
• Postprandial (2-4 hours after eating): think reactive hypoglycemia, post-bariatric
• Random: medication-induced, factitious

In diabetic patients, ask:

• Current diabetes medications (insulin, sulfonylureas, meglitinides)
• Recent dose changes
• Missed meals or reduced food intake
• Increased physical activity
• Alcohol use
• Renal function changes (prolongs insulin/sulfonylurea action)
• Recent illness
• Frequency and severity of hypoglycemia episodes
• Hypoglycemia awareness status

In non-diabetic patients, ask:

• Access to diabetes medications (family members, healthcare workers)
• Alcohol use (inhibits gluconeogenesis)
• Recent weight loss
• History of gastric surgery (dumping syndrome)
• Adrenal or pituitary disease
• Liver disease
• Eating patterns (prolonged fasting, eating disorders)
• Supplement use (some contain hidden hypoglycemic agents)

Medication review:

• Insulin (most common cause in diabetics)
• Sulfonylureas (glipizide, glyburide, glimepiride)
• Meglitinides (repaglinide, nateglinide)
• Alcohol
• Quinolones (rare)
• Pentamidine
• Quinine
• Beta-blockers (mask symptoms, don’t cause hypoglycemia)

Focused exam#

During hypoglycemic episode (if witnessed):

• Confirm low glucose with fingerstick
• Mental status assessment
• Diaphoresis, pallor, tremor
• Vital signs (tachycardia common)

Between episodes:

• Often normal exam
• Signs of underlying cause:
  • Cushingoid features then weight loss (adrenal insufficiency)
  • Hyperpigmentation (adrenal insufficiency)
  • Hepatomegaly (liver disease, glycogen storage disease)
  • Surgical scars (gastric bypass)
  • Injection sites (insulin use—look for lipohypertrophy)

Neurologic:

• Mental status
• Focal deficits (if prolonged severe hypoglycemia)

Skin:

• Injection sites (abdomen, thighs, arms)
• Lipohypertrophy at injection sites
• Signs of malnutrition

Differential (quick pattern recognition)#

Common/likely (outpatient)#

Can’t-miss / urgent#

Workup#

For diabetic patients with hypoglycemia:

• Usually no labs needed—cause is medication
• Review glucose logs, medication doses, meal patterns
• Check A1c (if overtreatment suspected)
• Check renal function (CKD prolongs sulfonylurea/insulin action)

For non-diabetic patients with suspected hypoglycemia:

First, confirm Whipple’s triad:

1. Document symptoms
2. Document low glucose during symptoms (<55 mg/dL in non-diabetics)
3. Document symptom resolution with glucose

If Whipple’s triad confirmed, check during hypoglycemic episode:

Interpretation of results:

Additional workup based on suspicion:

72-hour supervised fast:

• Gold standard for diagnosing insulinoma
• Done inpatient under endocrinology supervision
• Not a PCP test—refer if insulinoma suspected

When NOT to order extensive workup:

• Diabetic patient with clear medication-related cause
• Symptoms without documented low glucose (not true hypoglycemia)
• Postprandial symptoms that resolve with dietary changes

Initial management#

Acute treatment of hypoglycemia (Rule of 15):

1. Check glucose
2. If <70 mg/dL and patient can swallow: give 15-20g fast-acting carbohydrate
   • 4 glucose tablets
   • 4 oz juice or regular soda
   • 1 tablespoon honey or sugar
3. Recheck glucose in 15 minutes
4. Repeat if still <70 mg/dL
5. Once >70 mg/dL, eat a snack or meal to prevent recurrence

If patient cannot take oral glucose:

• Glucagon 1 mg IM/SC (or nasal glucagon)
• Call 911 for IV dextrose
• Position patient on side (aspiration risk)

Do NOT give oral glucose to unconscious patient (aspiration risk)

Management by diagnosis#

Medication-induced hypoglycemia (diabetic patients)#

Education:

• Recognize symptoms early
• Always carry fast-acting glucose
• Check glucose before driving
• Wear medical ID
• Teach family/friends how to help

Prevention strategies:

Medication adjustments:

Hypoglycemia unawareness:

• Relax glycemic targets (A1c 7.5-8%)
• Strict avoidance of hypoglycemia for 2-3 weeks can restore awareness
• Consider CGM (continuous glucose monitor)
• Refer to endocrinology if severe or recurrent

Glucagon prescribing:

• Prescribe for all patients on insulin
• Consider for patients on sulfonylureas with history of severe hypoglycemia
• Options: Glucagon injection kit (requires reconstitution), nasal glucagon (Baqsimi), auto-injector (Gvoke)
• Teach family/caregivers how to use
• Nasal glucagon is easier to administer but more expensive

Follow-up: 1-2 weeks after medication adjustment; sooner if severe or recurrent.

Reactive (postprandial) hypoglycemia#

Education:

• Not dangerous but uncomfortable
• Related to rapid glucose swings after eating
• Dietary changes are the main treatment

Treatment:

When to refer: If symptoms persist despite dietary changes, or if fasting hypoglycemia develops (suggests different diagnosis).

Follow-up: 4-6 weeks after dietary changes.

Post-bariatric hypoglycemia (dumping syndrome / late dumping)#

Education:

• Common after gastric bypass, less common after sleeve
• Related to rapid glucose absorption then excessive insulin release
• Usually manageable with diet

Treatment:

Refer to: Bariatric surgery team and/or endocrinology if dietary changes insufficient.

Insulinoma#

Recognition:

• Fasting hypoglycemia in non-diabetic
• Weight gain (eating to prevent symptoms)
• Whipple’s triad confirmed
• High insulin and C-peptide during hypoglycemia

PCP role:

• Recognize pattern (fasting hypoglycemia, weight gain)
• Refer to endocrinology for 72-hour fast and workup
• Do NOT attempt to diagnose or manage in primary care

Treatment: Surgical resection (curative in most cases)

Adrenal insufficiency#

Recognition:

• Hypoglycemia + fatigue + weight loss + hypotension
• May have hyperpigmentation (primary) or other pituitary deficiencies (secondary)

PCP role:

• Check morning cortisol (if <3 mcg/dL, highly suggestive; if >15 mcg/dL, rules out)
• If borderline, refer for ACTH stimulation test
• If confirmed, start hydrocortisone and refer to endocrinology

Do NOT delay treatment if adrenal crisis suspected—give stress-dose steroids and send to ED.

Follow-up#

Diabetic patients with hypoglycemia:

• 1-2 weeks after medication adjustment
• Review glucose logs
• Assess for recurrence
• Reinforce education

Non-diabetic patients:

• Depends on suspected cause
• Reactive hypoglycemia: 4-6 weeks after dietary changes
• Suspected insulinoma or other serious cause: urgent endocrinology referral

Return precautions:

• Severe hypoglycemia (confusion, seizure, loss of consciousness)
• Recurrent hypoglycemia despite adjustments
• Hypoglycemia while fasting (suggests serious cause)
• New symptoms (weight loss, fatigue, abdominal pain)

Patient instructions#

For diabetic patients:

• Low blood sugar (hypoglycemia) happens when your blood sugar drops too low, usually below 70.
• Symptoms include shakiness, sweating, fast heartbeat, hunger, confusion, and irritability.
• If you feel these symptoms, check your blood sugar if possible, then eat or drink 15 grams of fast-acting sugar (4 glucose tablets, 4 oz juice, or regular soda).
• Wait 15 minutes and recheck. Repeat if still low.
• Once your sugar is above 70, eat a snack with protein (crackers and cheese, peanut butter).
• Always carry glucose tablets or candy with you.
• Do not drive if your blood sugar is low or you feel symptoms.
• Wear a medical ID bracelet or necklace.
• Teach your family and friends how to recognize low blood sugar and how to help you.
• If you pass out or can’t swallow, someone should give you glucagon (if available) and call 911.

For non-diabetic patients with reactive hypoglycemia:

• Your blood sugar drops after eating, especially after sugary or starchy foods.
• Eat smaller, more frequent meals (5-6 times a day).
• Avoid sugary foods and drinks, white bread, and other refined carbs.
• Include protein and fiber with every meal and snack.
• Don’t skip meals.
• If you feel symptoms, eat a small snack with protein.

Smartphrase snippets#

.HYPOGLYCEMIADIABETIC Hypoglycemia in patient with diabetes. Patient reports [symptoms] with documented glucose of [value]. Likely cause: [insulin dose/sulfonylurea/missed meal/increased activity]. Current regimen: [medications]. Plan: [Reduce insulin by X% / Switch from glyburide to glipizide / Reduce sulfonylurea dose]. Reviewed hypoglycemia recognition and treatment (Rule of 15). Patient to carry glucose tablets. Recheck glucose logs in 1-2 weeks. Return if severe or recurrent hypoglycemia.

.HYPOGLYCEMIAREACTIVE Patient reports postprandial symptoms consistent with reactive hypoglycemia occurring [2-4 hours] after meals, particularly after [high-carb meals]. Symptoms include [shakiness/sweating/hunger] and resolve with eating. No fasting hypoglycemia. Whipple’s triad [documented/not documented]. Plan: Dietary modification—small frequent meals, avoid simple sugars, increase protein and fiber. Follow-up in 4-6 weeks. If symptoms persist or fasting hypoglycemia develops, will pursue further workup.

.HYPOGLYCEMIAWORKUP Non-diabetic patient with recurrent hypoglycemia. Whipple’s triad [confirmed/suspected]. Symptoms occur [fasting/postprandial]. No access to diabetes medications. Differential includes [insulinoma/adrenal insufficiency/factitious/post-bariatric]. Plan: [If during episode: check glucose, insulin, C-peptide, proinsulin, beta-hydroxybutyrate, sulfonylurea screen / Morning cortisol / Refer to endocrinology for 72-hour fast]. Patient advised to document symptoms and glucose readings.

Related pages#

• Type 2 Diabetes (problem) — comprehensive diabetes management including hypoglycemia prevention
• Hyperglycemia symptoms — diabetes diagnosis and management
• Weight gain — insulinoma can cause weight gain from frequent eating
• Fatigue — hypoglycemia as cause of fatigue
• Syncope — hypoglycemia in differential for loss of consciousness

Coding/billing notes#

• E16.0: Drug-induced hypoglycemia without coma
• E16.1: Other hypoglycemia (includes reactive, functional)
• E16.2: Hypoglycemia, unspecified
• E15: Hypoglycemic coma, nondiabetic
• E13.649: Other specified diabetes with hypoglycemia without coma
• E11.649: Type 2 diabetes with hypoglycemia without coma
• E10.649: Type 1 diabetes with hypoglycemia without coma
• D13.7: Benign neoplasm of endocrine pancreas (insulinoma)